ICGP Logo

Foundation Course in Addiction Management in Primary Care

Primarily aimed at GPs and GP registrars, this course will introduce the participant to managing issues related to alcohol misuse, misuse of prescription and over-the-counter medications as well as illicit drug use in primary care. 

  • Primarily aimed at GPs and GP registrars, this course will introduce the participant to managing issues related to alcohol misuse, misuse of prescription and over-the-counter medications as well as illicit drug use in primary care. 

    Upon completion, successful applicants will receive a certificate of successful completion / CPD code: 5 external credits/0.5 day GMS study leave

    You MUST retain a copy of your certificate in your records. 

    Note: Completion of this course enables you to apply for a HSE Level 1 GP contract.  You will be required to submit your certificate to apply for this contract. 

    Read more about applying for an HSE Level 1 GP Contract

    • ICGP members and GP registrars: No cost
    • Non-members: €100 application fee
    • 11 interactive eLearning presentations (ranging from 6 to 20 minutes in duration)
    • Links to all guidelines and assessment tools provided
    • All 11 topics must be viewed in sequence and 80% achieved in the MCQ assessment. You may log in and out of the training at your convenience and as often as you like.
    • Note: You may repeat the assessment up to a maximum of three times.

Management of Benzodiazepines and Z-Drugs

The aim of this self-directed, online programme is to educate healthcare professionals on the legislation pertaining to benzodiazepines and z-drugs and to the implications this has on their management in practice.

  • This programme was designed in conjunction with the HSE Medicine Management Programme, the Irish Institute of Pharmacy and the ICGP.

    The aim of this self-directed, online programme is to educate healthcare professionals on the legislation pertaining to benzodiazepines and z-drugs and to the implications this has on their management in practice. Course content will include examination of national guidelines relating to the management of benzodiazepines and z-drugs in clinical practice, details of the legislative requirements and the implications of this on practice, an investigation of the current issues that pertain to benzodiazepines and z-drugs, and possible strategies that could be employed in a collaborative approach for addressing these. The training programme will include interactive learning opportunities that incorporates examples and scenarios from primary practice.

    After successful completion of course videos and MCQs, students will be awarded certificate of successful completion / CPD code: 3 external credits/0.5 day GMS study leave. MCQ assessment may be repeated a maximum of 3 times. 

    This course is open to ICGP members only, and is free of charge.

  • At the end of this programme, GPs will be able to:

    • Identify the general factors that must be considered in the management of benzodiazepines and z-drugs in the primary care setting;
    • Understand the implications of the introduction of the Misuse of Drugs Regulations 2017 on the prescribing and dispensing of benzodiazepines and z-drugs;
    • Articulate the specific factors that should be addressed by practitioners in the prescribing, supply and ongoing review of patients who are taking benzodiazepines and z-drugs;
    • Identify the potential risks associated with benzodiazepines and z-drugs in the primary care setting and strategies to mitigate these;
    • Describe strategies that could be employed in a collaborative approach to patient care in the management of benzodiazepines and z-drugs.

Hepatitis Treatment in Primary Care

This eLearning module addresses all aspects of HCV management, including epidemiology, natural history, screening, testing, treatment, post-treatment follow up and prevention.

  • This eLearning module provides current and practical information for GPs and other members of the Primary Care Team, addressing all aspects of HCV management – including epidemiology, natural history, screening, testing, treatment, post-treatment follow up and prevention.

    Those who successfully complete the course (view all videos and achieve 80% on the MCQ) will be accredited to treat HCV in primary care by the National HCV Programme. Please send your certificate of completion to nhctp@hse.ie who will facilitate access to the programme for you. 

  • This is a free course that is open to all members with a specific emphasis on Level 1 and 2 GPs.

    Non-members on the HSE Central Treatment List (Level 1 & 2 contract holders) are also eligible to join.

Suboxone Training for Level 1 and 2 GPs

This training video guides Level 1 and 2 GPs through the most common opioid substitution treatment, Suboxone.

  • Buprenorphine is a partial opioid agonist that works effectively as on opioid substitution treatment (OST). Buprenorphine is often combined with naloxone, which acts as a deterrent to illicit intravenous use. The product used most often in Ireland is Suboxone. Buprenorphine can be used as an alternative to methadone. There are some important differences between these medications, which will be detailed in the training module.

    The training video is approximately 60 minutes in duration and is followed by a 10 question MCQ, which has an 80% successful completion mark. Once successfully completed, you can download a completion certificate. This training module is now a compulsory part of both level 1 and 2 training.

  • This course is free of charge and open to members of the Irish College of GPs only.

Overdose Management

This training video on overdose management, an important and growing global public health issue, was produced in conjunction with the HSE Inclusion Health Office.

  • Drug-related deaths are an important and growing global public health issue. There is a general consensus in the drug treatment community that this public health concern does not get the priority or importance needed to address the increasing numbers of young people dying of drug overdoses. People who use opioids and people who inject drugs (PWIDs) are of increased risk of drug-related deaths. Within this community, polydrug (particularly benzodiazepines and alcohol), homeless and older drug users are at further risk. New preliminary figures from the Health Research board (HRB) on drug-related deaths show there were 409 poisoning deaths in 2020. Naloxone, an opioid antagonist, is extremely effective in reversing opioid-related overdose and can play an important role in preventing fatal overdoses

    The Irish College of GPs, in conjunction with the HSE Inclusion Health Office, has developed a training video on overdose management that is now available to all members. The video is approximately 30 minutes long and is followed by 10 MCQ questions.

    On successful completion (80%) you will be issued with a certificate of satisfactory completion. This module is particular important for Level 1 and 2 OST prescribers, and will be part of both Level 1 and 2 training courses going forward.

  • This course is free and open to all members with a specific emphasis on Level 1 and 2 GPs.